Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2010-11-09A Pilot Randomised Controlled Trial of Acceptance and Commitment Therapy for Distress Following Psychosis
-
CLINICAL_TRIALS study record update · 2010-11-02A Single Dose Study of the Safety, Tolerability, and Pharmacokinetics of ABT-126 in Stable Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-10-28Contrasting the Brain Effects of Risperidone and Invega With fMRI and PET Scanning
-
CLINICAL_TRIALS study record update · 2010-10-27A Non-interventional Study Evaluating Well-being/Quality of Life in Schizophrenic Patients Treated With Seroquel XR® (Quetiapine) and Other Atypical Antipsychotics.A 9-month, Observational, Multicentric Prospective Study.
-
CLINICAL_TRIALS study record update · 2010-10-22A Randomized, Open-label Study Comparing the Effects of Olanzapine Pamoate Depot With Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2010-10-18Risperdal Safety Protocol Evaluation Consta Treatment; A Post Authorization Safety Survey With RISPERDAL CONSTA TM
-
CLINICAL_TRIALS study record update · 2010-10-15Single-Blind, Randomised, Placebo-Controlled Two-Part Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Escalating Doses and Repeat Doses of GSK729327 in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2010-10-13A Single-center, Open-label, 2-way Crossover Relative Bioavailability and Safety Trial With Two Differing Strength Tablets (3 x 5 mg vs. 1 x 15 mg) of Sublingually Administered Org 5222 in Subjects With Schizophrenia or Schizoaffective Disorder.
-
CLINICAL_TRIALS study record update · 2010-09-27A Multinational, Randomised, Double-Blind, Fixed-Dose, Bifeprunox Study Combining a 12-Week Placebo-Controlled, Quetiapine-Referenced Phase With a 12-Month Quetiapine-Controlled Phase in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-09-27Augmenting Clozapine With Sertindole - a Double Blinded Randomized Placebo Study
-
CLINICAL_TRIALS study record update · 2010-09-27A Multinational, Randomised, Double-blind, Fixed-dose, Bifeprunox Study Combining a 12-Week Placebo-controlled, Quetiapine-referenced Phase With a 12-month Quetiapine-controlled Phase in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-08-31A Randomized, Parallel Group, Double Blind, Placebo Controlled, Clinical Trial of Augmentation With Atomoxetine for the Treatment of Negative Symptoms in Patients With Schizophrenia and Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2010-08-25Entacapone Augmentation for Schizophrenia- A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2010-08-25A Randomized, Open Label, Rater Blind, Flexible Dose Multi-Center Study Comparing The Efficacy And Safety Of Intramuscular Ziprasidone With Haloperidol For Three Days In Patients With Agitation Of Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-08-16Reduction of Cardiovascular Risk in Severe Mental Illness Prescribing and Using Better and More Appropriated Drugs
-
CLINICAL_TRIALS study record update · 2010-08-12A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With Clozapine
-
CLINICAL_TRIALS study record update · 2010-08-10CONSTATRE: Risperdal Consta Trial Of Relapse Prevention And Effectiveness
-
CLINICAL_TRIALS study record update · 2010-08-09Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness
-
CLINICAL_TRIALS study record update · 2010-08-06A Phase IIa, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Oral Multiple Ascending Doses of AZD0328 in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-08-06Investigate the Effect of S-Ketamine, as Pharmacological Model of Schizophrenia, on the Attentiveness and Working Memory Simultaneously Measured With Functional Magnetic Resonance Imaging(fMRI)/Electroencephalogram(EEG)
-
CLINICAL_TRIALS study record update · 2010-08-03Effects of the Serotonin 2A Receptor on Insulin Sensitivity and Secretion: a Double-blind Controlled Comparison of Olanzapine vs. Amisulpride:
-
CLINICAL_TRIALS study record update · 2010-07-29A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Compare Metabolic Effects of Paliperidone ER and Olanzapine in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-07-28The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan
-
CLINICAL_TRIALS study record update · 2010-07-23Naturalistic Prospective Follow-Up of Patients With Schizophrenia or Bipolar Disorders Receiving Atypical Antipsychotics and/or Mood Stabilizers
-
CLINICAL_TRIALS study record update · 2010-07-23The Effectiveness Of Auricular Acupressure On Body Weight Parameters On Patients With Schizophrenia